Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs
Authors:
- Andrew D. BeamerABAndrew D. Beamer
- Catherine CantillonCCCatherine Cantillon
- Noreen McGowanNMNoreen McGowan
- Peter L. FriedmanPFPeter L. Friedman
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Usefulness of propafenone for recurrent paroxysmal atrial fibrillationThe American Journal of Cardiology, 1989
- Therapeutic efficacy and safety of oral propafenone for atrial fibrillationThe American Journal of Cardiology, 1989
- Long-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutterJACC, 1988
- Propafenone for prevention of recurrent atrial fibrillationThe American Journal of Cardiology, 1988
- Propafenone for paroxysmal atrial fibrillationThe American Journal of Cardiology, 1988
- Sotalol: A beta blocker with unique antiarrhythmic propertiesAmerican Heart Journal, 1987
- Atrial Fibrillation—a Review of Course and PrognosisActa Medica Scandinavica, 1984
- Inter- and intraatrial dissociation during spontaneous atrial flutter: Evidence for a focal origin of the arrhythmiaThe American Journal of Cardiology, 1982
- Coexistence of sick sinus rhythm and atrial flutter-fibrillation.Circulation, 1981
- Effect of sotalol on clinical arrhythmiasThe American Journal of Cardiology, 1972